According to a survey of 200 migraine specialists attending the American Headache Society meeting, increasing public funds for research is considered most promising. The majority believe new therapies will evolve from more investment in the field, while others see public awareness and education as crucial.
Research suggests the thalamus acts as a center for transmitting migraine pain, regulating its intensity and sensitivity to environmental stimuli. This new understanding may lead to future treatments targeting the thalamus.
Researchers gather to share new scientific data on migraine disease, exploring its unique role of the thalamus, recent gene identification, and childhood abuse correlations. Migraine specialists welcome a new era of discovery and advancement in understanding and treating this disabling disease.
Researchers found that migraine sufferers often experience fatigue, anxiety, mood changes, and yawning before an attack. Early intervention using triptans during the premonitory phase may help prevent or reduce the severity of attacks.
A gene discovery for migraine may lead to the development of a preventive pill that blocks the brain's pain channel. The discovery is significant as it opens understanding of the pain pathways that trigger migraine pain, sparking excitement among researchers and the pharmaceutical industry.
A notable prevalence of childhood abuse in migraine patients has been observed, with experts suggesting that early abuse may create permanent changes in the neurobiological system. Researchers are exploring the idea that treatment with serotonin-specific reuptake inhibitors may reverse some of these effects and decrease migraine pain.